BioCentury | Dec 19, 2019
Finance

Truffle’s recipe for company creation

...Paris-based Truffle Capital has closed its €250 million ($277.9 million) BioMedTech fund to create new drug and...
BioCentury | Jan 12, 2018
Financial News

Truffle Capital raises $102M toward life science and medtech fund

...Life sciences and information technology VC Truffle Capital raised $102 million toward its planned $240 million Truffle...
...S.A. (Euronext:ABVX) and neurology play Pharnext S.A.S. (Euronext:ALPHA). The firm manages $1.1 billion in assets. Truffle Capital...
BioCentury | Jan 10, 2018
Financial News

Truffle Capital raises $102M toward life science and medtech fund

...Life sciences and information technology VC Truffle Capital raised $102 million toward its planned $240 million Truffle...
BioCentury | Apr 15, 2015
Financial News

Venture tracks

Venture firm Truffle Capital promoted Antoine Pau to partner. Pau had been an investment director. BC Staff...
BioCentury | Feb 23, 2015
Financial News

Vaxin completes venture financing

...Infectious Date completed: 2015-02-17 Type: Venture financing Raised: $16 million Investors: Novartis Venture Funds; HealthCap; Truffle Capital...
BioCentury | May 26, 2014
Finance

Europe's Iceberg 2014: Divergent appetites

...Capital (formerly Rock Spring Ventures) Rock Spring Ventures EU (RSV-EU) U.K. £50 ($79) (A) Jan-13 Truffle Capital...
BioCentury | Feb 24, 2014
Company News

Cuban Center for Genetic Engineering and Biotechnology (CIGB), Truffle Capital infectious, cancer news

...and B cell responses. Cuban Center for Genetic Engineering and Biotechnology (CIGB) , Havana, Cuba Truffle Capital...
BioCentury | May 27, 2013
Finance

Demand disequilibrium

...Truffle Capital (B) France $67 Feb-12 LSP-Life Sciences Partners LSP-Health Economics Fund Germany; Netherlands $65 Mar-13 Truffle Capital...
BioCentury | Apr 1, 2013
Financial News

Truffle Capital financial update

...European private equity firm Truffle Capital said it plans to raise €40 million ($52 million) this year...
...company Theradiag (Euronext:ALTER, Marne La Vallee, France) and autoimmune company Neovacs S.A. (Euronext:ALNEV, Paris, France). Truffle Capital...
BioCentury | Jan 28, 2013
Financial News

Truffle Capital financial update

...European private equity firm Truffle Capital said it raised €50 million ($66.5 million) from retail investors in...
...Theradiag (Euronext:ALTER, Marne La Vallee, France) and autoimmune company Neovacs S.A. (Euronext:ALNEV, Paris, France). *** Truffle Capital...
Items per page:
1 - 10 of 27
BioCentury | Dec 19, 2019
Finance

Truffle’s recipe for company creation

...Paris-based Truffle Capital has closed its €250 million ($277.9 million) BioMedTech fund to create new drug and...
BioCentury | Jan 12, 2018
Financial News

Truffle Capital raises $102M toward life science and medtech fund

...Life sciences and information technology VC Truffle Capital raised $102 million toward its planned $240 million Truffle...
...S.A. (Euronext:ABVX) and neurology play Pharnext S.A.S. (Euronext:ALPHA). The firm manages $1.1 billion in assets. Truffle Capital...
BioCentury | Jan 10, 2018
Financial News

Truffle Capital raises $102M toward life science and medtech fund

...Life sciences and information technology VC Truffle Capital raised $102 million toward its planned $240 million Truffle...
BioCentury | Apr 15, 2015
Financial News

Venture tracks

Venture firm Truffle Capital promoted Antoine Pau to partner. Pau had been an investment director. BC Staff...
BioCentury | Feb 23, 2015
Financial News

Vaxin completes venture financing

...Infectious Date completed: 2015-02-17 Type: Venture financing Raised: $16 million Investors: Novartis Venture Funds; HealthCap; Truffle Capital...
BioCentury | May 26, 2014
Finance

Europe's Iceberg 2014: Divergent appetites

...Capital (formerly Rock Spring Ventures) Rock Spring Ventures EU (RSV-EU) U.K. £50 ($79) (A) Jan-13 Truffle Capital...
BioCentury | Feb 24, 2014
Company News

Cuban Center for Genetic Engineering and Biotechnology (CIGB), Truffle Capital infectious, cancer news

...and B cell responses. Cuban Center for Genetic Engineering and Biotechnology (CIGB) , Havana, Cuba Truffle Capital...
BioCentury | May 27, 2013
Finance

Demand disequilibrium

...Truffle Capital (B) France $67 Feb-12 LSP-Life Sciences Partners LSP-Health Economics Fund Germany; Netherlands $65 Mar-13 Truffle Capital...
BioCentury | Apr 1, 2013
Financial News

Truffle Capital financial update

...European private equity firm Truffle Capital said it plans to raise €40 million ($52 million) this year...
...company Theradiag (Euronext:ALTER, Marne La Vallee, France) and autoimmune company Neovacs S.A. (Euronext:ALNEV, Paris, France). Truffle Capital...
BioCentury | Jan 28, 2013
Financial News

Truffle Capital financial update

...European private equity firm Truffle Capital said it raised €50 million ($66.5 million) from retail investors in...
...Theradiag (Euronext:ALTER, Marne La Vallee, France) and autoimmune company Neovacs S.A. (Euronext:ALNEV, Paris, France). *** Truffle Capital...
Items per page:
1 - 10 of 27